Acid ceramidase as a therapeutic target in metastatic prostate cancer
Open Access
- 1 May 2013
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 54 (5) , 1207-1220
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cellsJournal of Clinical Investigation, 2012
- C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growthBreast Cancer Research and Treatment, 2011
- Regulation of sphingosine kinase and sphingolipid signalingTrends in Biochemical Sciences, 2011
- Ceramide in Stem Cell Differentiation and Embryo Development: Novel Functions of a Topological Cell-Signaling Lipid and the Concept of Ceramide CompartmentsJournal of Lipids, 2010
- Inhibition of acid ceramidase by a 2‐substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N‐(4‐hydroxyphenyl) retinamideThe Prostate, 2010
- A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber diseaseJournal of Lipid Research, 2010
- Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicityBreast Cancer Research, 2009
- Implication of Ceramide, Ceramide 1-Phosphate and Sphingosine 1-Phosphate in Tumorigenesis2008
- Thiol Proteases: Inhibitors and Potential Therapeutic TargetsCurrent Medicinal Chemistry, 2006
- The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenograftsThe Prostate, 2003